{"name":"Alterity Therapeutics","slug":"alterity-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","status":"active","statusNote":"","leadDrug":"","leadIndication":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMivwJBVV95cUxQYmw5SkoxVEYwZldReFJlS0IyLUwxa2hQbUNUa2FMdGNTeTVpTHZmSXNRM3UxeWVaMmRYUU1KNldFU1lGNzBZczdKay1NYzFfb3JFNmtGVmxUT0lSQVh5TjU5V2ducnJ2VzVnb1BiT0lIOW5zbXBBLVk4ZEllRGNwOS1sYVhBRFF2US03WVdpX09ia19iRUlteUg2V2U1NGhHWU1rUllmNFJYYmJleDlMd09PdzBTV1VvSXRDSWdHZmVUQVNBQVJNcENGVWc4NGd2OU5hbTlKd1NWbk1uZmlrVXYwYWRzWXp3cy1HU1lkVW1VWDg2Y1BrdnhibG1ZMnFPYV93bk9WVmpQcFlqME52OHpPRUxoR1RFVlBhMktMazVJU29ZMmdEcTBoMl9FZGhvTm5makctTHNSRTFwSUpr?oc=5","date":"2026-04-03","type":"pipeline","source":"The Globe and Mail","summary":"Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and enGene Holdings (ENGN) - The Globe and Mail","headline":"Analysts Offer Insights on Healthcare Companies: Alterity Therapeutics (OtherPRNAF), Tarsus Pharmaceuticals (TARS) and e","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizwJBVV95cUxOOGhDYjBKcUZXZGY0SmRFLWlXYWdxWDJFa1NFY2hGZE5IcUxTSlNYZkJUenNNTGpjSnhqMHM1RmJmaTVNZVN5WjRzY2N6a1ZqRnZzN3F0QTBUdzdQMzVxVkNsSEg2V3pQYWJBTHBsTzVxdHNaaHpoaXdrVUw0Tm00SEtHeks3YXVDSUF1blZSV2t5bVBXTlYtelFyclIxcGU2WUFzTTFNN09kd1JKbkhYaVVUSVZuT292TnEtbTJ5Tm9Ta0NONDFoYkxLUlF0UUNDUEs1V25xVHFyRzVjSVhaMVJFeTMteEFBNGFPVnNBYUswNHYzc0tEVzV4akNsakZIRGVrTUx2Z0d0WGNLY1g3SW41SVc2ckg3djVTVmNRQUxZQ0NpSi14RTN1cDk2ZnRZY1FlZjBRSnh1ZUpOS0ptMF9VY2Z2VlcwYm84WmhpOA?oc=5","date":"2026-04-03","type":"pipeline","source":"Barchart.com","summary":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven Pharma, Lundbeck A/S, Alterity Therapeutics, Theravance Biopharma, Brain Neuro -","headline":"Multiple System Atrophy Market: High-Growth Opportunities for Investors to 2034 – DelveInsight | Ionis Pharma, Biohaven ","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxQbDhMNERQUzdIUXdIczJVbVI5QktEOTdVb1cwejlIaXYxVU5KYmFqekE1SUVHRjlqa3VHanZtek5oaV9WN1U4c19xOWJyNURmUWRJallGRXI4N0pzY0xIY2Q5NlVqU25yWWJMSTlnS1lfelphTmxhaWVvQWdHTVk4aXZ6ZnE2QjZtcWw2SHF6LTVJaXo1OWFYcWZfTXVQSmVCVjhTM1Ewaw?oc=5","date":"2026-03-30","type":"pipeline","source":"PharmaDispatch","summary":"Alterity Therapeutics updates investors on key meeting with US regulator - PharmaDispatch","headline":"Alterity Therapeutics updates investors on key meeting with US regulator","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxPR29PLVEyTW1FUXNTaXBhcVFMalFyZ29ObjdpUWhIeUk2RnVXak5Yak93aUxkOWRUYkZZbmNvQTFiclRpLUZXQWF1ckZlRm5JRkU3TDVyd0kzU3VFYkd6UG9XRm94Y1ZaZXZBdGlQN1dEM0h6OUN1REhhLTFaSzczWUJhWS1rVUZudUo3NGxZQjdWd29mZ2dHM2JmQ2JWNEhKZUNkYmdibktwVmxySEtKazFzV3NkRmo1RHhWVUdab1FlZXF5SUhFbTJWVTBEUkFiYlZNY2JURVpJWHZLSUxFT3ZOSy1wal9LVHc?oc=5","date":"2026-03-09","type":"pipeline","source":"GlobeNewswire","summary":"Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit - GlobeNewswire","headline":"Alterity Therapeutics to Participate in the Bell Potter Healthcare Horizons Summit","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxObDhIaWZIV3lXRkNZVG5obVZ5eW1IZ0ZsaVVyOUFfLXZXdVF1WUZpaFRrbW9rbTBZMWM2U1Mwb0pDaGdreEdFbmVaZUdnWUZNb3NBaFpvVjZIQXE4Qm1yblFObC1Gc2hPUDNLeGlNV2xaM3MtbmlHdGZualdUbTh3cmc0TVduVF9NT0ZabjdTWFkzVEFkX2VacFB3RFBId0pSTUVRTExWUjFldVU5ek9IejhYYXZ1cjFJdmJXRFJOSUw?oc=5","date":"2026-01-30","type":"trial","source":"Stock Titan","summary":"Experimental MSA drug ATH434 inches toward Phase 3 on stronger data - Stock Titan","headline":"Experimental MSA drug ATH434 inches toward Phase 3 on stronger data","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxNbFNGZ2xjZk1DelI5R1RXUzRJZnZmT2xxWnFFVXJxbkRBanI4bUNaTHAwN2kzVkZTbEtaWUtwVlEwNDZuT21SaG90TlBoMERGdkw0NndvMGFGTGRiMTcwdTVkWVhvTHpIWENuMW5VdGxIdFk0ZnE0Zk9jMG5NaTRlQW43LUw0aHNSMkZNWWYyemlaeFBHXzREd1NTX0praTE2Wk9iMXR0MnRNemdoRFBRTFltb3piNG42YmRtQVZB?oc=5","date":"2025-12-04","type":"pipeline","source":"Stockhead","summary":"Health Check: Researchers find new ways to navigate the Alzheimer’s disease treatment maze - Stockhead","headline":"Health Check: Researchers find new ways to navigate the Alzheimer’s disease treatment maze","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-31","type":"earnings","source":"simplywall.st","summary":"When Can We Expect A Profit From Alterity Therapeutics Limited (ASX:ATH)? - simplywall.st","headline":"When Can We Expect A Profit From Alterity Therapeutics Limited (ASX:ATH)?","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-31","type":"pipeline","source":"simplywall.st","summary":"We Think Alterity Therapeutics (ASX:ATH) Can Easily Afford To Drive Business Growth - simplywall.st","headline":"We Think Alterity Therapeutics (ASX:ATH) Can Easily Afford To Drive Business Growth","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwwFBVV95cUxNeFZSeW8wNE9MbTBhZVMwQ1AyZU5YdTJDZEM2TFZOdnhNanQ2Z0VIcjNYenB3c0hQeXdhY0o0cl9NcjRTN1QyYWMzLUpwaXF4emp0Vnc3d0VmQ1lZRzRxN1BNbXR3blltYUNhYllza0duZzkyaERkYW90Q2kycENZMlZzcC01d2FfSVZ4OUVmeU9iaGVfbW1xdnlYVVowSXRiMEtqZ1pGbHNZaHBtcENhQnBoVnEwVVhGNFNNR0s2WWhfbm8?oc=5","date":"2025-08-25","type":"trial","source":"News-Medical","summary":"New study reveals long road to seizure control for people with focal epilepsy - News-Medical","headline":"New study reveals long road to seizure control for people with focal epilepsy - News","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwJBVV95cUxNbjJpMUlyUXpZeHFYNUlhNDJBbWp4TXdxN3ZwZ1E5UHh6Q3lVWUhIa01QOU10VWFHWXhwTUpWZ19EV1Z3QW9EakJOUVpuUUFmREdHQnVWS3ZRN2I4WF9HVDZfODloVTg4ZTMwWG9wMUNnbEU1N1haNkJOQXRpUV9lWWVmdk1fYlpCbTlTUUtxczBObTNibWotTm9iRUFTOGpIbFpDM3BwbklBRExmUHB2d1Bialpaa1lNa1N2WnJmNzltTVFSVldfem1la3VXMG5YbkRPMlBBMVdnOHZ6MzVwWWhhWHByZ29UZ25hUnVBLWdYMWZ2OXZMVDlaZXdBdl8tSVBB?oc=5","date":"2025-02-17","type":"pipeline","source":"PR Newswire","summary":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight - PR Newswire","headline":"Multiple System Atrophy Market Set to Experience Significant Growth with Breakthrough Therapies by 2034 | DelveInsight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTE5qRlEydTJSNm03ekZOZUJRaEJfQVczT3J5UUFZYlN0ZmVSZ3JlUUJlMEREZk91Sl9naUlacmUxejM0UEpScUhvdHpNQUxDdE10aklB?oc=5","date":"2025-01-30","type":"trial","source":"FirstWord Pharma","summary":"Alterity surges after iron chaperone hits key goals in multi-system atrophy trial - FirstWord Pharma","headline":"Alterity surges after iron chaperone hits key goals in multi-system atrophy trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiUkFVX3lxTFBVRW1ZYVFEaTZLYVU0dlZRQlZoYThHblNpWG5EbEdvWTI2NmlwVDBkS1hSeTM5czZTcE1vMkVJZWZtVWVrMjdSR1V5QWVTYTl6dGc?oc=5","date":"2020-02-28","type":"pipeline","source":"Yahoo! Finance Canada","summary":"Alterity Therapeutics Limited (ATHE) Stock Price, News, Quote & History - Yahoo! Finance Canada","headline":"Alterity Therapeutics Limited (ATHE) Stock Price, News, Quote & History - Yahoo! Finance Canada","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}